
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Long-term effects of insulin glargine on the risk of breast cancer”, Diabetologia, vol. 54, pp. 2254-62, 2011.
, “Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events”, Eur Respir J, vol. 49, 2017.
, “Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study”, Chest, vol. 151, pp. 60-67, 2017.
, “Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 459-468, 2017.
, “Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study”, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
, “Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice”, Chest, 2019.
, , “Comparative Effectiveness of Initial LAMA versus LABA in COPD: Real-World Cohort Study”, Copd, vol. 18, pp. 1-8, 2021.
,